PHARMACOTHERAPY FOR NON-ALCOHOLIC FATTY LIVER DISEASE: EMERGING TARGETS AND DRUG CANDIDATES

Descargar Publicación
Obesity and Cancer: Potential Mediation by Dysregulated Dietary Phosphate Posible nuevo fármaco para la obesidad se dirige a ensayos de fase II